Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Masonic Cancer Center, University of Minnesota
University of California, San Francisco
Barbara Ann Karmanos Cancer Institute
Mayo Clinic